Fatal Donor-Derived Carbapenem-Resistant<i> Klebsiella pneumoniae</i> Infection in a Combined Kidney-Pancreas Transplantation

Varotti, Giovanni; Dodi, Ferdinando; Marchese, Anna; Terulla, Alessia; Bertocchi, Massimo; Fontana, Iris

doi:https://doi.org/10.1155/2016/7920951

Case Reports in Transplantation

On this page

Abstract Introduction Case Report Discussion Abbreviations References Copyright Related Articles

Case Report | Open Access

Volume 2016 | Article ID 7920951 | https://doi.org/10.1155/2016/7920951

Fatal Donor-Derived Carbapenem-Resistant Klebsiella pneumoniae Infection in a Combined Kidney-Pancreas Transplantation

Giovanni Varotti,¹Ferdinando Dodi,²Anna Marchese,³Alessia Terulla,¹Massimo Bertocchi,¹and Iris Fontana¹

Academic Editor: Graeme Forrest

Received05 Aug 2016

Accepted28 Sept 2016

Published16 Oct 2016

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in solid organ transplant recipients are associated with high morbidity and mortality. We report a case of a fatal donor-derived CR-KP infection in a combined kidney-pancreas transplant. Given the short interval of time between donor hospitalization and organ procurement, information concerning the donor CR-KP positivity arrived only 72 hours after transplant. Based on this experience, we believe that knowledge of the donor’s CR-KP status should be mandatory before procurement and, if positive, pancreas donation should be contraindicated.

1. Introduction

First described in 2001 concerning an isolate collected in a North Carolina Hospital in 1996, CR-KP infections have spread rapidly worldwide, becoming a serious healthcare problem associated with increased cost and length of stay as well as worse patient outcomes [1, 2]. Its impact can be particularly devastating in solid organ transplant recipients, as they are a very high-risk population because of either their immunosuppressed status or their prolonged hospitalization [3, 4].

Moreover, given their stay in intensive care units under mechanical ventilation and their severe illness requiring vasopressor support, deceased multiorgan donors are also another high-risk category for CR-KP transmission, leading potentially to donor-derived infection of recipients [5].

Unfortunately, definitive information concerning the donor’s cultures may be still unknown during the times of procurement and implantation, resulting in an indefinite risk for donor-derived CR-KP transmission.

2. Case Report

We report the case of a 37-year-old diabetic female, who underwent a combined kidney-pancreas transplant in our centre in April 2014.

Donor was a 26-year-old male who remained in ICU for only 18 hours before procurement and was considered a “standard” risk for infections.

Simultaneous pancreas and left kidney transplant was performed by first placing the pancreatic graft in the right lower intraperitoneal cavity, with vascularization on the recipient’s right common iliac axis and a duodenoenterostomy for the exocrine drainage. Then a standard kidney transplant was performed placing the graft in the left iliac fossa.

Intravenous (IV) amoxicillin doses were continued for 48 hours as perioperative antibiotic prophylaxis.

On POD 3, the donor’s sputum, bronchoalveolar lavage cultures, and the rectal swab were positive for carbapenem-resistant Klebsiella pneumoniae (CR-KP), susceptible only to colistin ( mg/L); the donor’s blood cultures were negative. Combined IV preemptive antibiotic therapy with colistin (loading dose: 9.000.000 IU, maintenance dose: 2.000.000 IU/BID), meropenem (dose: 2 gr./BID), and tigecycline (loading dose: 100 mg, maintenance dose: 50 mg/BID) was started.

Four days later, the recipient’s blood cultures revealed a CR-KP infection and a picture of peritonitis required an urgent relaparotomy which showed an enteric leak from duodenoileal anastomosis with surrounding necrotic tissue, which imposed the removal of the pancreatic graft.

Evidence of CR-KP was confirmed in the intraoperative swabs collected from the duodenal graft.

Comparison of all the donor’s isolates to the recipient’s blood isolate by pulsed-field gel electrophoresis [1] revealed an identical profile, confirming the donor-derived infection. The identifications of the KPC-3 gene were achieved by PCR and sequencing using primers and conditions previously described [6]. Genomic DNA was prepared, digested with XbaI (New England Biolabs Inc., MA, USA) and subjected to PFGE with the CHEF DRII device (Bio-Rad, Milan, Italy). All isolates exhibited the same PFGE macrorestriction profile, confirming the donor-derived infections.

Antibiotic was continued for six weeks, until cultures tested negative; on POD 70, the patient was discharged with normal kidney function, remaining colonized for CR-KP by positive rectal swab.

One month later, the patient was readmitted for a pseudoaneurysm of the right common iliac artery with surrounding liquid collection, found to be CR-KP positive and colistin resistant ( mg/L, EUCAST confirmed). Patient underwent right iliac replacement with heterologous homograft which was then infected by CR-KP requiring a subsequent silver graft substitution. Triple IV antibiotic therapy with ertapenem (500 mg/daily), meropenem (2 g/BID), and tigecycline (loading dose: 100 mg, maintenance dose: 50 mg/BID) was reintroduced but the iliac wound cultures remained CR-KP positive, subsequently developing a picture of sepsis. In the following weeks, the patient’s condition progressively worsened and, unfortunately, she died as a result of multiorgan failure 195 days after transplant.

3. Discussion

There is very little data on this argument and, to the best of our knowledge, this is the first case reporting a donor-derived CR-KP infection in a kidney-pancreas transplant recipient. In the 15 published cases of donor-derived CR-KP infection in solid organ transplant (5 kidneys, 5 livers, 3 lungs, 1 combined liver-kidney, and 1 heart), 13 had an uneventful outcome while 2 recipients died (one after receiving a lung from an asymptomatic carrier of CR-KP in the respiratory tract and one after receiving a kidney from a donor with CR-KP urine infection) [3–5, 7, 8]. These initial experiences suggest that, in well-defined conditions and following a strict follow-up, organs from colonized CR-KP donors may be considered for transplantation, avoiding their use when the donor’s blood cultures were positive or when the organ is directly involved in CR-KP infection, such as lungs in the case of the airway infection or kidneys in urinary tract isolation [7, 8].

However, our experience revealed peculiar aspects of pancreas donation. In a colonized subject, the CR-KP bacteria remain silent and mainly at the level of the gastrointestinal tract; in this setting, in the event of a pancreas transplant in which the graft necessarily includes a duodenal tract, there could be a high potential risk of direct bacterial transmission from the duodenal graft to the recipient.

In our case, the intraoperative swab collected proved the presence of CR-KP bacteria in the explanted duodenal graft. However, we cannot state that the CR-KP infection was directly responsible for the duodenal-ileal anastomotic leak but it was certainly one of the main causes of the sequence of unfavourable events which led to the patient’s death. As a result of this experience, we believe that pancreas donation should also be contraindicated in the event of colonized CR-KP donors.

Given the short time interval between donor hospitalization and organ procurement (<24 hours), we learnt of the positivity of the rectal swab only three days after transplant. We believe it would be crucial to receive this information before harvesting, to optimize the organ allocation process. These reasons highlight the importance of prompt interinstitutional information sharing among the donor’s hospital doctors, local organ coordination centre, and transplant teams. Moreover, we believe that in selected cases, such as ours, the use of faster diagnostic assays such as real-time PCR [9, 10] should be encouraged for rapid CR-KP detection.

Abbreviations

CR-KP:	Carbapenem-resistant Klebsiella pneumoniae
ICU:	Intensive care units.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

L. S. Munoz-Price, L. Poirel, R. A. Bonomo et al., “Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases,” The Lancet Infectious Diseases, vol. 13, no. 9, pp. 785–796, 2013.
View at: Publisher Site | Google Scholar
J. A. Fishman and P. A. Grossi, “Donor-derived infection-the challenge for transplant safety,” Nature Reviews Nephrology, vol. 10, no. 11, pp. 663–672, 2014.
View at: Publisher Site | Google Scholar
E. Goldberg, J. Bishara, S. Lev, P. Singer, and J. Cohen, “Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report,” Transplant Infectious Disease, vol. 14, no. 3, pp. 296–299, 2012.
View at: Publisher Site | Google Scholar
A. Mularoni, A. Bertani, G. Vizzini et al., “Outcome of transplantation using organs from donors infected or colonized with carbapenem-resistant gram-negative bacteria,” American Journal of Transplantation, vol. 15, no. 10, pp. 2674–2682, 2015.
View at: Publisher Site | Google Scholar
J. Bishara, E. Goldberg, S. Lev, P. Singer, T. Ashkenazi, and J. Cohen, “The utilization of solid organs for transplantation in the setting of infection with multidrug-resistant organisms: an expert opinion,” Clinical Transplantation, vol. 26, no. 6, pp. 811–815, 2012.
View at: Publisher Site | Google Scholar
A. Marchese, E. Coppo, R. Barbieri, and E. Debbia, “Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation Unit of an Italian hospital,” Journal of Chemotherapy, vol. 22, no. 3, pp. 212–214, 2010.
View at: Publisher Site | Google Scholar
E. J. Ariza-Heredia, R. Patel, E. A. Blumberg et al., “Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae,” Transplant Infectious Disease, vol. 14, no. 3, pp. 229–236, 2012.
View at: Publisher Site | Google Scholar
T. Giani, V. Conte, S. Mandalà et al., “Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor,” Journal of Clinical Microbiology, vol. 52, no. 7, pp. 2702–2705, 2014.
View at: Publisher Site | Google Scholar
M. Hindiyeh, G. Smollen, Z. Grossman et al., “Rapid detection of blaKPC carbapenemase genes by real-time PCR,” Journal of Clinical Microbiology, vol. 46, no. 9, pp. 2879–2883, 2008.
View at: Publisher Site | Google Scholar
J. M. Cole, A. N. Schuetz, C. E. Hill, and F. S. Nolte, “Development and evaluation of a real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes,” Journal of Clinical Microbiology, vol. 47, no. 2, pp. 322–326, 2009.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 Giovanni Varotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies